Status:

RECRUITING

Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults

Lead Sponsor:

Kennesaw State University

Conditions:

Dyslipidemia

Insulin Resistance Syndrome

Eligibility:

All Genders

20+ years

Phase:

NA

Brief Summary

The prevalence of overweight and obesity remains epidemic in the United States, with some of the highest rates seen in older adults. While this phenomenon is certainly multifactorial, a good deal of e...

Detailed Description

Aim 1: Quantify the relationship between average steps·kg fat mass-1·day-1 and body composition/CMR profiles in healthy normal, overweight, and obese adults 20-39 years, 40-59 years, 60-79 years, and ...

Eligibility Criteria

Inclusion

  • ages of 20 years and older
  • otherwise healthy adults on prescription medication to treat hypertension or osteoarthritic conditions are eligible to participate
  • sedentary people, or people who report engaging in regular walking (no regular structured exercise for at least the past six months)
  • relatively stable weight over the previous 6 months (less than 5% fluctuation in body weight)

Exclusion

  • any diagnosed cardiovascular, metabolic, renal, or pulmonary disease, or any diagnosed cognitive dysfunction
  • women who are pregnant or plan on becoming pregnant
  • people taking prescription medication to regulate plasma glucose, or that affect metabolism (e.g., thyroid medication)
  • people who have undergone an increase or decrease in body weight of ≥ 5% over the previous six months
  • current smokers
  • people who have engaged in a program of structured exercise other than walking (e.g., weight training, jogging, swimming, cycling) within that last six months
  • older adults (60-plus years old) who score \> 4 on the Short Blessed Test for geriatric cognitive impairment during the first lab visit will be ineligible to participate

Key Trial Info

Start Date :

January 13 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 31 2027

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT07221279

Start Date

January 13 2025

End Date

August 31 2027

Last Update

October 27 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kennesaw State Universityh

Kennesaw, Georgia, United States, 30144